Cost Effectiveness Analysis Treatment of Pediatric Pneumonia Antibiotic Ceftriaxon and Cefotaxime at Dr. Chasbullah Abdulmadjid Hospital

Malaysian Journal of Medicine and Health Sciences Pub Date : 2023-08-10 DOI:10.47836/mjmhs.19.s9.15

Ninda Laelasari, Maratun Shoaliha, Fauziah H Wada, Ashar Prima, Sandeep Poddar

{"title":"Cost Effectiveness Analysis Treatment of Pediatric Pneumonia Antibiotic Ceftriaxon and Cefotaxime at Dr. Chasbullah Abdulmadjid Hospital","authors":"Ninda Laelasari, Maratun Shoaliha, Fauziah H Wada, Ashar Prima, Sandeep Poddar","doi":"10.47836/mjmhs.19.s9.15","DOIUrl":null,"url":null,"abstract":"Introduction: Pneumonia is inflammation in the lung parenchyma. Inflammation occurs due to infection by various organisms like bacteria, viruses, and others. This infection eventually causes the emergence of several signs and symptoms. Ceftriaxone and cefotaxime are antibiotics that are commonly and effectively used in the treatment of pneumonia. Methods: The purpose of this study is to determine the total cost of pneumonia treatment provided during hospitalization at RSUD Bekasi City. This research uses the method descriptive research with data retrieval retrospectively. The sample in this research totaled 68 patients, 34 patients used ceftriaxone antibiotics and 34 patients used cefotaxime antibiotics. Results: Cefotaxime antibiotic therapy is a more cost-effective therapy compared to Ceftriaxone. This study found the effectiveness of Ceftriaxone 88% and Cefotaxime 70% but did not reach 100% effectiveness due to the large number of patients whose length of stay (LOS) and respiration rate (RR) did not reach the target. The result showed that the average cost of treating patients with Ceftriaxone was Idr 2,171,651 and the average cost of treating patients with Cefotaxime was Idr 2,467,422. Conclusion: Ceftriaxone antibiotic therapy is a more cost-effective therapy compared to Cefotaxime which can be, seen from the ACER Ceftriaxone value of IRp. 24,677 and ICER value of Rp. -16,431.651 and the average cost of treating patients using Cefotaxime was Idr 2,467,422.","PeriodicalId":40029,"journal":{"name":"Malaysian Journal of Medicine and Health Sciences","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Malaysian Journal of Medicine and Health Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47836/mjmhs.19.s9.15","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Pneumonia is inflammation in the lung parenchyma. Inflammation occurs due to infection by various organisms like bacteria, viruses, and others. This infection eventually causes the emergence of several signs and symptoms. Ceftriaxone and cefotaxime are antibiotics that are commonly and effectively used in the treatment of pneumonia. Methods: The purpose of this study is to determine the total cost of pneumonia treatment provided during hospitalization at RSUD Bekasi City. This research uses the method descriptive research with data retrieval retrospectively. The sample in this research totaled 68 patients, 34 patients used ceftriaxone antibiotics and 34 patients used cefotaxime antibiotics. Results: Cefotaxime antibiotic therapy is a more cost-effective therapy compared to Ceftriaxone. This study found the effectiveness of Ceftriaxone 88% and Cefotaxime 70% but did not reach 100% effectiveness due to the large number of patients whose length of stay (LOS) and respiration rate (RR) did not reach the target. The result showed that the average cost of treating patients with Ceftriaxone was Idr 2,171,651 and the average cost of treating patients with Cefotaxime was Idr 2,467,422. Conclusion: Ceftriaxone antibiotic therapy is a more cost-effective therapy compared to Cefotaxime which can be, seen from the ACER Ceftriaxone value of IRp. 24,677 and ICER value of Rp. -16,431.651 and the average cost of treating patients using Cefotaxime was Idr 2,467,422.

查看原文本刊更多论文

Dr. Chasbullah Abdulmadjid医院头孢曲松和头孢噻肟治疗儿童肺炎的成本-效果分析

肺炎是肺实质的炎症。炎症是由细菌、病毒等各种生物体的感染引起的。这种感染最终会导致出现几种体征和症状。头孢曲松和头孢噻肟是治疗肺炎常用且有效的抗生素。方法:本研究的目的是确定在别加西市RSUD住院期间提供的肺炎治疗的总成本。本研究采用回顾性资料检索的描述性研究方法。本研究样本共68例，头孢曲松类抗生素34例，头孢噻肟类抗生素34例。结果:头孢噻肟抗生素治疗比头孢曲松更具成本效益。本研究发现头孢曲松的有效率为88%，头孢噻肟的有效率为70%，但由于大量患者的住院时间(LOS)和呼吸率(RR)未达到目标，因此没有达到100%的有效率。结果显示，头孢曲松治疗患者的平均费用为2171651印尼盾，头孢噻肟治疗患者的平均费用为2467422印尼盾。结论:头孢曲松抗生素治疗较头孢噻肟更具成本效益，从ACER头孢曲松的IRp值可以看出。24,677和Rp的ICER值。-16,431.651，使用头孢噻肟治疗患者的平均费用为2,467,422卢比。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Malaysian Journal of Medicine and Health Sciences Medicine-Medicine (all)

CiteScore

0.50

自引率

0.00%

发文量

期刊介绍： The Malaysian Journal of Medicine and Health Sciences (MJMHS) is published by the Faculty of Medicine and Health Sciences, Universiti Putra Malaysia. The main aim of the MJMHS is to be a premier journal on all aspects of medicine and health sciences in Malaysia and internationally. The focus of the MJMHS will be on results of original scientific research and development, emerging issues and policy analyses pertaining to medical, biomedical and clinical sciences.